List of Excipients in API palonosetron
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing palonosetron
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Avyxa Pharma LLC | POSFREA | palonosetron | 83831-105 | MANNITOL | |
| Avyxa Pharma LLC | POSFREA | palonosetron | 83831-105 | SODIUM ACETATE | |
| Avyxa Pharma LLC | POSFREA | palonosetron | 83831-105 | WATER | |
| Accord Healthcare Inc | PALONOSETRON HYDROCHLORIDE | palonosetron hydrochloride | 16729-365 | CITRIC ACID MONOHYDRATE | |
| Accord Healthcare Inc | PALONOSETRON HYDROCHLORIDE | palonosetron hydrochloride | 16729-365 | EDETATE DISODIUM | |
| Accord Healthcare Inc | PALONOSETRON HYDROCHLORIDE | palonosetron hydrochloride | 16729-365 | MANNITOL | |
| Accord Healthcare Inc | PALONOSETRON HYDROCHLORIDE | palonosetron hydrochloride | 16729-365 | SODIUM CITRATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing palonosetron
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| NorthStar Rx LLC | palonosetron | 16714-834 | EDETATE DISODIUM |
| NorthStar Rx LLC | palonosetron | 16714-834 | MANNITOL |
| NorthStar Rx LLC | palonosetron | 16714-834 | SODIUM ACETATE |
| NorthStar Rx LLC | palonosetron | 16714-834 | WATER |
| DrReddy's Laboratories Limited | palonosetron | 55111-694 | EDETATE DISODIUM |
| DrReddy's Laboratories Limited | palonosetron | 55111-694 | MANNITOL |
| DrReddy's Laboratories Limited | palonosetron | 55111-694 | SODIUM ACETATE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for palonosetron
Excipient focus: ANHYDROUS CITRIC ACID
palonosetron drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Fresenius Kabi USA LLC | palonosetron | 63323-673 |
| >Company | >Ingredient | >NDC |
palonosetron drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: BUTYLATED HYDROXYANISOLE
palonosetron drug variants containing BUTYLATED HYDROXYANISOLE
| Company | Ingredient | NDC |
|---|---|---|
| Helsinn Therapeutics (US) Inc | palonosetron hydrochloride | 69639-104 |
| >Company | >Ingredient | >NDC |
palonosetron drug variants not containing BUTYLATED HYDROXYANISOLE
Excipient focus: CAPRYLIC/CAPRIC MONO/DI-GLYCERIDES
palonosetron drug variants containing CAPRYLIC/CAPRIC MONO/DI-GLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Helsinn Therapeutics (US) Inc | palonosetron hydrochloride | 69639-104 |
| >Company | >Ingredient | >NDC |
palonosetron drug variants not containing CAPRYLIC/CAPRIC MONO/DI-GLYCERIDES
Excipient focus: CITRIC ACID MONOHYDRATE
palonosetron drug variants containing CITRIC ACID MONOHYDRATE
palonosetron drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: EDETATE DISODIUM
palonosetron drug variants containing EDETATE DISODIUM
palonosetron drug variants not containing EDETATE DISODIUM
Excipient focus: GLYCERIN
palonosetron drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Helsinn Therapeutics (US) Inc | palonosetron hydrochloride | 69639-104 |
| >Company | >Ingredient | >NDC |
palonosetron drug variants not containing GLYCERIN
Excipient focus: GLYCINE
palonosetron drug variants containing GLYCINE
| Company | Ingredient | NDC |
|---|---|---|
| Ingenus Pharmaceuticals LLC | palonosetron hydrochloride | 50742-485 |
| >Company | >Ingredient | >NDC |
palonosetron drug variants not containing GLYCINE
Excipient focus: HYDROCHLORIC ACID
palonosetron drug variants containing HYDROCHLORIC ACID
palonosetron drug variants not containing HYDROCHLORIC ACID
Excipient focus: MANNITOL
palonosetron drug variants containing MANNITOL
palonosetron drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Helsinn Therapeutics (US) Inc | palonosetron hydrochloride | 69639-104 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYGLYCERYL-10 OLEATE
palonosetron drug variants containing POLYGLYCERYL-10 OLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Helsinn Therapeutics (US) Inc | palonosetron hydrochloride | 69639-104 |
| >Company | >Ingredient | >NDC |
palonosetron drug variants not containing POLYGLYCERYL-10 OLEATE
Excipient focus: SODIUM ACETATE
palonosetron drug variants containing SODIUM ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar Rx LLC | palonosetron | 16714-834 |
| DrReddy's Laboratories Limited | palonosetron | 55111-694 |
| BluePoint Laboratories | palonosetron | 68001-355 |
| Avyxa Pharma LLC | palonosetron | 83831-105 |
| >Company | >Ingredient | >NDC |
palonosetron drug variants not containing SODIUM ACETATE
Excipient focus: SODIUM CITRATE
palonosetron drug variants containing SODIUM CITRATE
palonosetron drug variants not containing SODIUM CITRATE
Excipient focus: SODIUM HYDROXIDE
palonosetron drug variants containing SODIUM HYDROXIDE
palonosetron drug variants not containing SODIUM HYDROXIDE
Excipient focus: TRISODIUM CITRATE DIHYDRATE
palonosetron drug variants containing TRISODIUM CITRATE DIHYDRATE
palonosetron drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: WATER
palonosetron drug variants containing WATER
palonosetron drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Fresenius Kabi USA LLC | palonosetron | 63323-673 |
| Ingenus Pharmaceuticals LLC | palonosetron hydrochloride | 50742-485 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
